Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
Transforming surgical drainage with intelligent digital devices to reduce complications and costs in patients recovering from cardiothoracic surgery.
World’s first fully disposable, single-incision laparoscopic surgical device with multiple integrated technologies: stapler, grasper and dual-camera with in-line digital display for multiple common surgeries for faster surgery, quick recovery from single small hole and shorter anesthesia.
Moray Medical is harnessing robotics to democratize edge-to-edge mitral valve repair. The company's initial product is the Coral system, which will combine augmented reality (AR) visualization, a digital user interface, and microfluidics to simplify mitral valve repair procedures.
CorInnova is developing a minimally invasive, soft robotic cardiac device for the short-term treatment of acute heart failure.
Nyra Medical is developing an image-guided, catheter-based intervention, called the cardiac leaflet enhancer (CARLEN), for the treatment of mitral and/or tricuspid regurgitation in heart failure patients.
Synova Life Sciences a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells.
Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.
Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access.
User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.
Mindera's SkinAtlas is a scalable platform that leverages artificial intelligence and machine learning to analyze patient-specific data collected from a dermal biomarker patch.
True Digital Surgery develops next-generation solutions for the operating room. The company's flagship system, Occipta, is a heads-up, digital mircoscope and imaging platform intended to improve surgeons' control and visualization capabilities during reconstructive surgery.
A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence.
CoapTech has developed a minimally invasive ultrasound for use in creating gastrostomies. The PUMA-G system is FDA-cleared to guide enteral feeding tube placement at the bedside.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more.
Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO). A novel first-line therapy used during PCI to positively change the course for Acute MI patients.
Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength.
Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
Levita Magnetics' innovative magnetic surgical platform, called Magnetic Surgery®, is the next step in the evolution of less invasive surgery.
Carevature Medical develops advanced orthopedic solutions to address limitations of current surgical solutions.
By combining expertise in 3D printing with advanced biomaterials and artificial intelligence, restor3d is creating patient-specific orthopedic implants to reconstruct and repair the human body.
Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients.
The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.
A lively discussion to explore lessons learned and opportunities ahead.
Lucid is developing solutions to help clinicians diagnose and manage the progression of esophageal disease.
Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD), one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.
Transforming surgery through robotics and virtual reality. The Vicarious Surgical robot will offer surgeons a 360 degree view and reach within the patient and surgical field.
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3D printing to create an implant which can permanently repair debilitating joint injuries.
OYE (Open Your Eyes) Therapeutic's intervention is set to remove over $5.5B in annual avoidable costs from US hospitals and surgery centers by solving the defined problem of delayed operating room turnover due to extended emergence time from anesthesia.
Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.
